Sign In

Save up to 80% by drug discount in your pharmacy with "Pharmacy Near Me - National Drug Discount Card"

You can scan QR Code(just open camera on your phone/scan by application) from the image on prescription drug discount card to save it to your mobile phone. Or just click on image if you're on mobile phone.

View Generic:
View Brand:

Cetirizine hcl - Medication Information

Product NDC Code 72657-128
Drug Name

Cetirizine hcl

Type Brand
Pharm Class Histamine H1 Receptor Antagonists [MoA],
Histamine-1 Receptor Antagonist [EPC]
Active Ingredients
Cetirizine hydrochloride 5 mg/1
Route ORAL
Dosage Form TABLET
RxCUI drug identifier 1014676,
1014678
Application Number ANDA078427
Labeler Name GLENMARK THERAPEUTICS INC., USA
Packages
Package NDC Code Description
72657-128-03 1 bottle in 1 carton (72657-128-03) / 300 tablet in 1 bottle
72657-128-04 1 bottle in 1 carton (72657-128-04) / 400 tablet in 1 bottle
72657-128-08 1 bottle in 1 carton (72657-128-08) / 120 tablet in 1 bottle
72657-128-14 1 bottle in 1 carton (72657-128-14) / 140 tablet in 1 bottle
72657-128-15 1 bottle in 1 carton (72657-128-15) / 150 tablet in 1 bottle
72657-128-18 1 bottle in 1 carton (72657-128-18) / 180 tablet in 1 bottle
72657-128-24 1 bottle in 1 carton (72657-128-24) / 240 tablet in 1 bottle
72657-128-30 1 bottle in 1 carton (72657-128-30) / 30 tablet in 1 bottle
72657-128-35 1 bottle in 1 carton (72657-128-35) / 365 tablet in 1 bottle
72657-128-45 1 bottle in 1 carton (72657-128-45) / 45 tablet in 1 bottle
72657-128-60 1 bottle in 1 carton (72657-128-60) / 60 tablet in 1 bottle
72657-128-70 1 bottle in 1 carton (72657-128-70) / 70 tablet in 1 bottle
72657-128-81 2 bottle in 1 carton (72657-128-81) / 60 tablet in 1 bottle
72657-128-82 2 bottle in 1 carton (72657-128-82) / 70 tablet in 1 bottle
72657-128-84 2 bottle in 1 carton (72657-128-84) / 90 tablet in 1 bottle
72657-128-86 2 bottle in 1 carton (72657-128-86) / 120 tablet in 1 bottle
72657-128-90 1 bottle in 1 carton (72657-128-90) / 90 tablet in 1 bottle
Check if available Online

Active ingredient

A list of the active, medicinal ingredients in the drug product.
Cetirizine HCl 5 mg Cetirizine HCl 10 mg

Dosage and administration

Information about the drug product’s dosage and administration recommendations, including starting dose, dose range, titration regimens, and any other clinically sigificant information that affects dosing recommendations.
Cetirizine Hydrochloride Tablets, USP 5 mg adults and children 6 years and over 1 tablet (5 mg) or 2 tablets (10) once daily depending upon severity of symptoms; do not take more than 2 tablets (10) in 24 hours. adults 65 years and over 1 tablet (5 mg) once a day; do not take more than 1 tablet (5 mg) in 24 hours. children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor Cetirizine Hydrochloride Tablets, USP 10 mg adults and children 6 years and over one 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms. adults 65 years and over ask a doctor children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
adults and children 6 years and over1 tablet (5 mg) or 2 tablets (10) once daily depending upon severity of symptoms; do not take more than 2 tablets (10) in 24 hours.
adults 65 years and over1 tablet (5 mg) once a day; do not take more than 1 tablet (5 mg) in 24 hours.
children under 6 years of ageask a doctor
consumers with liver or kidney diseaseask a doctor
adults and children 6 years and overone 10 mg tablet once daily; do not take more than one 10 mg tablet in 24 hours.A 5 mg product may be appropriate for less severe symptoms.
adults 65 years and overask a doctor
children under 6 years of ageask a doctor
consumers with liver or kidney diseaseask a doctor

Inactive ingredient

A list of inactive, non-medicinal ingredients in a drug product.
colloidal silicon dioxide, croscarmellose sodium, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide

Indications and usage

A statement of each of the drug products indications for use, such as for the treatment, prevention, mitigation, cure, or diagnosis of a disease or condition, or of a manifestation of a recognized disease or condition, or for the relief of symptoms associated with a recognized disease or condition. This field may also describe any relevant limitations of use.
Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: • runny nose, • sneezing, • itchy, watery eyes, • itching of the nose or throat

Purpose

Information about the drug product’s indications for use.
Antihistamine

Spl product data elements

Usually a list of ingredients in a drug product.
Cetirizine HCl Cetirizine CETIRIZINE HYDROCHLORIDE CETIRIZINE SILICON DIOXIDE HYPROMELLOSE, UNSPECIFIED LACTOSE MONOHYDRATE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL, UNSPECIFIED POVIDONE K30 SODIUM STARCH GLYCOLATE TYPE A TITANIUM DIOXIDE C;13 Cetirizine HCl Cetirizine CETIRIZINE HYDROCHLORIDE CETIRIZINE SILICON DIOXIDE HYPROMELLOSE, UNSPECIFIED LACTOSE MONOHYDRATE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL, UNSPECIFIED POVIDONE K30 SODIUM STARCH GLYCOLATE TYPE A TITANIUM DIOXIDE C;17 Cetirizine HCl Cetirizine Cetirizine HCl Cetirizine CETIRIZINE HYDROCHLORIDE CETIRIZINE SILICON DIOXIDE HYPROMELLOSE, UNSPECIFIED LACTOSE MONOHYDRATE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL, UNSPECIFIED POVIDONE K30 SODIUM STARCH GLYCOLATE TYPE A TITANIUM DIOXIDE C;13 Cetirizine HCl Cetirizine CETIRIZINE HYDROCHLORIDE CETIRIZINE SILICON DIOXIDE HYPROMELLOSE, UNSPECIFIED LACTOSE MONOHYDRATE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL, UNSPECIFIED POVIDONE K30 SODIUM STARCH GLYCOLATE TYPE A TITANIUM DIOXIDE C;13 Cetirizine HCl Cetirizine Cetirizine HCl Cetirizine CETIRIZINE HYDROCHLORIDE CETIRIZINE SILICON DIOXIDE HYPROMELLOSE, UNSPECIFIED LACTOSE MONOHYDRATE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL, UNSPECIFIED POVIDONE K30 SODIUM STARCH GLYCOLATE TYPE A TITANIUM DIOXIDE C;17 Cetirizine HCl Cetirizine CETIRIZINE HYDROCHLORIDE CETIRIZINE SILICON DIOXIDE HYPROMELLOSE, UNSPECIFIED LACTOSE MONOHYDRATE MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL, UNSPECIFIED POVIDONE K30 SODIUM STARCH GLYCOLATE TYPE A TITANIUM DIOXIDE C;17

Package label principal display panel

The content of the principal display panel of the product package, usually including the product’s name, dosage forms, and other key information about the drug product.
Principal Display Panel 5mg365label Principal Display Panel 10mg365label Principal Display Panel NDC 72657-130-89 5 mg - 150 Tablets (contains one bottle of 60 Tablets and one bottle of 90 Tablets 5mgkit Principal Display Panel 10mgkit

Spl unclassified section

Information not classified as belonging to one of the other fields. Approximately 40% of labeling with effective_time between June 2009 and August 2014 have information in this field.
Other information • store between 20°C to 25°C (68°F to 77°F) • do not use of imprinted foil inner seal on bottle is broken or missing. • FDA approved organic impurities test procedure differs from USP

Keep out of reach of children

Information pertaining to whether the product should be kept out of the reach of children, and instructions about what to do in the case of accidental contact or ingestion, if appropriate.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222)

Other safety information

Information about safe use and handling of the product that may not have been specified in another field.
Questions or comments? call toll-free weekdays 9 AM to 5 PM EST at 1 (888) 721-7115 Manufactured by: Glenmark Pharmaceuticals Limited Pithampur, Madhya Pradesh 454775, India Distributed by: Glenmark Therapeutics Inc., USA Mahwah, NJ 07430 Product of India February 2024

Warnings

Information about serious adverse reactions and potential safety hazards, including limitations in use imposed by those hazards and steps that should be taken if they occur.
Do not use if you have ever had an allergic reaction to this product or any of its ingredients or an antihistamine containing hydroxyzine Ask a doctor before useif you have liver or kidney disease. Your doctor should determine if you need a different dose. Ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives When using this product • drowsiness may occur • avoid alcoholic drinks • alcohol, sedatives, and tranquilizers may increase drowsiness • be careful when driving a motor vehicle or operating machinery Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away. If pregnant or breast-feeding: • If breast-feeding: not recommended • if pregnant: ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222)

Disclaimer: Do not rely on openFDA or Phanrmacy Near Me to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Source: OpenFDA, Healthporta Drugs API